Poly-(L -lactic acid) and citric acid-crosslinked gelatin composite matrices as a drug-eluting stent coating material with endothelialization, antithrombogenic, and drug release properties

Journal of Biomedical Materials Research - Part A

Volumn 101 A, Issue 7, 2013, Pages 2049-2057

  Inoue, Motoki ^a   Sasaki, Makoto ^a,b   Katada, Yasuyuki ^a   Fujiu, Katsuhito ^c   Manabe, Ichiro ^c   Nagai, Ryozo ^c   Taguchi, Tetsushi ^a,b  

^a NATIONAL INSTITUTE FOR MATERIALS SCIENCE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

citric acid; drug eluting stent (DES); gelatin; poly (L lactic acid) (PLLA); tamibarotene

Indexed keywords

BIODEGRADABLE COMPOSITES; DRUG RELEASE PROPERTIES; DRUG-ELUTING STENTS; ENDOTHELIALIZATION; GELATIN; PLLA; SMOOTH MUSCLE CELL PROLIFERATION; TAMIBAROTENE;

ARTIFICIAL ORGANS; CELL CULTURE; CITRIC ACID; COATINGS; CROSSLINKING; ENDOTHELIAL CELLS; LACTIC ACID; THICKNESS MEASUREMENT;

STENTS;

ALKALI TREATED GELATIN; CITRIC ACID; FIBRIN; GELATIN; POLYLACTIC ACID; TAMIBAROTENE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CROSS LINKING; DRUG ELUTING STENT; DRUG RELEASE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MALE; NONHUMAN; RAT; THROMBOCYTE;

ANIMALS; BENZOATES; CELL PROLIFERATION; CITRIC ACID; COMPOMERS; CROSS-LINKING REAGENTS; DELAYED-ACTION PREPARATIONS; DRUG-ELUTING STENTS; ENDOTHELIUM, VASCULAR; FIBRINOLYTIC AGENTS; GELATIN; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; LACTIC ACID; MALE; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; POLYGLYCOLIC ACID; RATS; RATS, WISTAR; SUCCINIMIDES; TETRAHYDRONAPHTHALENES; THROMBOSIS;

EID: 84878307620     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34488     Document Type: Article

References (43)

1. Fattori R, Piva T,. Drug-eluting stents in vascular intervention. Lancet 2003; 361: 247-249.
2. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME,. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350: 221-231.
3. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB,. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. New Engl J Med 2007; 356: 998-1008.
4. Farb A, Weber DK, Kolodgie FD, Burke AP, Virmani R,. Morphological predictors of restenosis after coronary stenting in humans. Circulation 2002; 105: 2974-2980.
5. Luscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC, Virmani R,. Drug-eluting stent and coronary thrombosis: Biological mechanisms and clinical implications. Circulation 2007; 115: 1051-1058.
6. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R,. Pathology of drug-eluting stents in humans. Delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48: 193-202.
7. Joner M, Nakazawa G, Finn AV, Quee SC, Coleman L, Acampado E, Wilson PS, Skorija K, Cheng Q, Xu X, Gold HK, Kolodgie FD, Virmani R,. Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol 2008; 52: 333-342.
8. Wilson GJ, Nakazawa G, Schwartz RS, Huibregtse B, Poff B, Herbst TJ, Baim DS, Virmani R,. Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries. Circulation 2009; 120: 141-149.
9. Mani G, Feldman MD, Patel D, Agrawal CM,. Coronary stents: A materials perspective. Biomaterials 2007; 28: 1689-1710.
10. Venkatraman S, Boey F,. Release profiles in drug-eluting stents: Issues and uncertainties. J Controlled Release 2007; 120: 149-160.
11. Puskas JE, Muñoz-Robledo LG, Hoerr RA, Foley J, Schmidt SP, Evancho-Chapman M, Dong J, Frethem C, Haugstad G,. Drug-eluting stent coatings. Wiley Interdisciplinary Rev: Nanomed Nanobiotechnol 2009; 1: 451-462.
12. Khan W, Farah S, Domb AJ,. Drug eluting stents: Developments and current status. J Controlled Release 2012; 161: 703-712.
13. John MC, Wessely R, Kastrati A, Schömig A, Joner M, Uchihashi M, Crimins J, Lajoie S, Kolodgie FD, Gold HK, Virmani R, Finn A,. Differential healing responses in polymer- and nonpolymer-based sirolimus-eluting stents. JACC: Cardiovasc Interv 2008; 1: 535-544.
14. Joner M, Nakazawa G, Finn AV, Quee SC, Coleman L, Acampado E, Wilson PS, Skorija K, Cheng Q, Xu X, Gold HK, Virmani R, Finn AV,. Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol 2008; 52: 333-342.
15. Wang X, Venkatraman SS, Boey FYC, Loo JSC, Tan LP,. Controlled release of sirolimus from a multilayered PLGA stent matrix. Biomaterials 2006; 27: 5588-5595.
16. Lincoff AM, Furst JG, Ellis SG, Tuch RJ, Topol EJ,. Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model. J Am Coll Cardiol 1997; 29: 808-816.
17. Jiang W, Schwendeman SP,. Stabilization and controlled release of bovine serum albumin encapsulated in poly(D, L -lactide) and poly(ethylene glycol) microsphere blends. Pharm Res 2001; 18: 878-885.
18. Schmidmaier G, Wildemann B, Stemberger A, Haas NP, Raschke M,. Biodegradable poly(D, L -lactide) coating of implants for continuous release of growth factors. J Biomed Mater Res 2001; 58: 449-455.
19. Lee JS, Kim SH, Kim YJ, Akaike T, Kim SC,. Hepatocyte adhesion on a poly[N-p-vinylbenzyl-4-O-β- D -galactopyranosyl- D -glucoamide]-coated poly(L -lactic acid) surface. Biomacromolecules 2005; 6: 1906-1911.
20. He W, Ma Z, Yong T, Teo WE, Ramakrishna S,. Fabrication of collagen-coated biodegradable polymer nanofiber mesh and its potential for endothelial cells growth. Biomaterials 2005; 26: 7606-7615.
21. Wan Y, Yang J, Bei J, Wang S,. Cell adhesion on gaseous plasma modified poly-(L -lactide) surface under shear stress field. Biomaterials 2003; 24: 3757-3764.
22. Young S, Wong M, Tabata Y, Mikos AG,. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Controlled Release 2005; 109: 256-274.
23. Taguchi T, Saito H, Iwasashi M, Sakane M, Ochiai N,. Biodegradable adhesives composed of human serum albumin and organic acid-based crosslinkers with active ester groups. J Bioactive Compatible Polym 2009; 24: 546-559.
24. Taguchi T, Saito H, Iwasashi M, Sakane M, Kakinoki S, Ochiai N, Tanaka J,. Development of a novel glue consisting of naturally-derived biomolecules: Citric acid and human serum albumin. J Nanosci Nanotechnol 2007; 7: 742-747.
25. Taguchi T, Saito H, Aoki H, Uchida Y, Sakane M, Kobayashi H, Tanaka J,. Biocompatible high-strength glue consisting of citric acid derivative and collagen. Mater Sci Eng 2006; 26C: 9-13.
26. Saito H, Taguchi T, Kobayashi H, Kataoka K, Tanaka J, Murabayashi S, Mitamura Y,. Physicochemical properties of gelatin gels prepared using citric acid derivative. Mater Sci Eng 2004; 24C: 781-785.
27. Inoue M, Sasaki M, Nakasu A, Takayanagi M, Taguchi T,. An antithrombogenic citric acid-crosslinked gelatin with endothelialization activity. Adv Healthc Mater 2012; 1: 573-581.
28. Inoue M, Sasaki M, Taguchi T,. Unusual degradation behavior of citric acid-crosslinked gelatin in vitro and in vivo. Polym Degrad Stab 2010; 95: 2088-2092.
29. Inoue M, Sasaki M, Katada Y, Taguchi T,. UV irradiation enhances the bonding strength between citric acid-crosslinked gelatin and stainless steel. Colloid Surf B 2011; 88: 260-264.
30. Sasaki M, Inoue M, Katada Y, Taguchi T,. The effect of VEGF-immobilized nickel-free high-nitrogen stainless steel on viability and proliferation of vascular endothelial cells. Colloid Surf B 2012; 92: 1-8.
31. Fujiu K, Manabe I, Ishihara A, Oishi Y, Iwata H, Nishimura G, Shindo T, Maemura K, Kagechika H, Shudo K, Nagai R. Synthetic retinoid Am80 suppresses smooth muscle phenotypic modulation and in-stent neointima formation by inhibiting KLF5. Circ Res 2005; 97: 1132-1141.
32. Shindo T, Manabe I, Fukushima Y, Tobe K, Aizawa K, Miyamoto S, Kawai-Kowase K, Moriyama N, Imai Y, Kawakami H, Nishimatsu H, Ishikawa T, Suzuki T, Morita H, Maemura K, Sata M, Hirata Y, Komukai M, Kagechika H, Kadowaki T, Kurabayashi M, Nagai R,. Kruppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat Med 2002; 8: 856-863.
33. Matsusaki M, Kamezawa T, Shimozuru T, Kuratsu JI, Kishida A, Akashi M,. Novel guglielmi detachable coils (GDCs) for the treatment of brain aneurysms. In vitro study of hydroxyapatite coating on Pt plate as GDCs model. J Biomed Mater Res 2003; 66B: 429-438.
34. Serizawa T, Yamaguchi M, Matsuyama T, Akashi M,. Alternating bioactivity of polymeric layer-by-layer assemblies: Anti- vs procoagulation of human blood on chitosan and dextran sulfate layers. Biomacromolecules 2000; 1: 306-309.
35. Lin Q, Yan J, Qiu F, Song X, Fu G, Ji J,. Heparin/collagen multilayer as a thromboresistant and endothelial favorable coating for intravascular stent. J Biomed Mater Res 2011; 96A: 132-141.
36. Liu H, Li X, Niu X, Zhou G, Li P, Fan Y,. Improved hemocompatibility and endothelialization of vascular grafts by covalent immobilization of sulfated silk fibroin on poly(lactic-co-glycolic acid) scaffolds. Biomacromolecules 2011; 12: 2914-2924.
37. Nguyen KT, Su SH, Sheng A, Wawro D, Schwade ND, Brouse CF, Greilich PE, Tang L, Eberhart RC,. In vitro hemocompatibility studies of drug-loaded poly-(L -lactic acid) fibers. Biomaterials 2003; 24: 5191-5201.
38. Saito H, Murabayashi S, Mitamura Y, Taguchi T,. Unusual cell adhesion and antithrombogenic behavior of citric acid-cross-linked collagen matrices. Biomacromolecules 2007; 8: 1992-1998.
39. Okano T, Uruno M, Sugiyama N, Shimada M, Shinohara I, Kataoka K, Sakurai Y,. Suppression of platelet activity on microdomain surfaces of 2-hydroxyethyl methacrylate-polyether block copolymers. J Biomed Mater Res 1986; 20: 1035-1047.
40. Maeda M, Kimura M, Inoue S,. Adhesion behavior of rat lymphocyte subpopulations (B cell and T cell) on the surface of polystyrene/polypeptide graft copolymer. J Biomed Mater Res 1986; 20: 25-35.
41. Nuttelman CR, Henry SM, Anseth KS,. Synthesis and characterization of photocrosslinkable, degradable poly(vinyl alcohol)-based tissue engineering scaffolds. Biomaterials 2002; 23: 3617-3626.
42. Lee JH, Go AK, Oh SH, Lee KE, Yuk SH,. Tissue anti-adhesion potential of ibuprofen-loaded PLLA-PEG diblock copolymer films. Biomaterials 2005; 26: 671-678.
43. Matsusue Y, Yamamuro T, Oka M, Shikinami Y, Hyon SH, Ikada Y,. In vitro and in vivo studies on bioabsorbable ultra-high-strength poly(L -lactide) rods. J Biomed Mater Res 1992; 26: 1553-1567.